Acute generalized exanthematous pustulosis suspected induced by cefadroxil after receiving the vaccine Covid-19: A case report
Keywords:
CoronaVac, Vaccine Covid-19, Cefadroxil, AGEPAbstract
Acute Generalized Exanthematous Pustulosis (AGEP) is a rare skin condition that is typically triggered by drug reactions, particularly antibiotics, but can also arise from infections or vaccinations. Its primary symptom is the sudden appearance of sterile pustules with erythematous, accompanied by systemic symptoms such as fever. Unless complicated by secondary infection, AGEP usually resolves spontaneously and has a favorable prognosis.References
Heelan K, Sibbald C, Shear N. Cutaneous reaction to drugs. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, Orringer JS, editors. Fitzpatrick’s Dermatology in General Medicine. 9th ed. New York: McGraw Hill Companies; 2019. p. 750-4.
Susanti RI, Mamuaja EH, Niode NJ. Acute generalized exanthem pustulosis. J Biomedik. 2017;9(3):449–59.
Duman H, Kocaturk E, Mansuroglu I, Topal IO, Cure K. Acute generalized exanthematous pustulosis induced by hydroxychloroquine: A case with atypical clinical presentation. An Bras Dermatol. 2017;92(3):404–6.
Belda W, Ferolla AC. Acute generalized exanthematous pustulosis (AGEP) case report. Rev Inst Med Trop S Paulo. 2005;47(3):171-6.
Lin Y-F, Yang C-H, Sindy H, Lin J-Y, Rosaline Hui C-Y, Tsai Y-C, et al. Severe cutaneous adverse reactions related to systemic antibiotics. Clin Infect Dis. 2014;58:1377–85.
Stingeni L, Francisci D, Bianchi L, Hansel K, Tramontana M, Di Candilo F, et al. Severe adverse drug reaction in SARS-CoV-2 infection: AGEP induced by ceftriaxone and confirmed b y a patch test. Contact Dermatitis. 2021;85(3):366–8.
World Health Organization, Pan American Health Organization, Update DC. Consolidated Regional and Global Information On Adverse Events Following Immunization (AEFI) Against COVID-19 and Other Updates. 2021;(12).
Kang S-Y, Park S-Y, Kim J-H, Lee SM, Lee SP. COVID-19 vaccine-induced acute generalized exanthematous pustulosis. Korean J Intern Med. 2021;36(6):1537-8.
Marina S, Kristina Semkova K, Gspideruleva D, Kazandjieva J. Acute generalized exanthematous pustulosis AGEP: a literature review. Scripta Scientifica Medica. 2013;45(4):7-12.
Sidoroff A, Dunant A, Viboud C, Halevy S, Bavinck JNB, Naldi L, et al. Risk factors for acute generalized exanthematous pustulosis (AGEP) - Results of a multinational case-control study (EuroSCAR). Br J Dermatol. 2007;157(5):989–96.
de Marco BA, Salgado HRN. Characteristics, properties and analytical methods of cefadroxil: A review. Crit Rev Anal Chem. 2017;47:93–8.
Lee YY, Chung WH. Acute generalized exanthematous pustulosis: A retrospective study of 51 cases in Taiwan. Dermatologica Sin. 2014;32(3):137–40. Available from: http://dx.doi.org/10.1016/j.dsi.2013.12.004
Speeckaert MM, Speeckaert S, Lambert J, Brochez L. Acute generalized exanthematous pustulosis: An overview of the clinical, immunological and diagnostic concepts. Eur J Dermatol. 2010;20(4):425-33.
Santimaleeworagun W, Traipattanakul J, Hemapanpairoa J. Acute Generalized Exanthematius Pustulosis Caused by a Selective Allergy to Imipenem-Cilastatin: A Case Report. Bangkok Med J. 2020;16(1):74–7.
Bouvresse S, Valeyrie-Allanore L, Ortonne N, Konstantinou MP, Kardaun SH, Bagot M, et al. Toxic epidermal necrolysis, DRESS, AGEP: do overlap cases exist? Orphanet J Rare Dis. 2012;7(72):1-5.
Vlachos C, Henning M, Gaitanis G, Faergemann J. and Saunte D. Critical synthesis of available data in Malassezia folliculitis and a systematic review of treatments. J Eur Acad Dermatol Venereol. 2020;34:1672-83.
https://doi.org/10.1111/jdv.16253.
